Arch Biopartners【ARCH】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.00

買値

2.00

売値

2.03

出来高

24,466

1.94 日の範囲 2.01

0.00 52 週間の範囲 0.00

時価総額

125.196M

前日終値

1.94

始値

1.97

時刻

300

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

発行済株式数

62,598,000

配当利回り

PER

-37.66

1 株当たり利益 (EPS)

-0.05

歳入

1.98M

純利益

-3.33M

セクター

Coml Physical, Biologcl Resh

業界

Advertising Agencies

ウェブサイト

archbiopartners.com

本社

Toronto, Ontario, Can

設立

2010

Arch Biopartners Inc is listed in the Coml Physical, Biologcl Resh sector of the トロントベンチャー取引所 with ticker ARCH. The last closing price for Arch Biopartners was $1.94. Over the last year, Arch Biopartners shares have traded in a share price range of $ 0.00 to $ 0.00.

Arch Biopartners currently has 62,598,000 shares in issue. The market capitalisation of Arch Biopartners is $121.44 million. Arch Biopartners has a price to earnings ratio (PE ratio) of -37.66.

Arch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing have begun...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Closes Units for Debt Settlement

TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has closed a transaction that...

Units for Debt Settlement

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a transaction to...

Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Alberta Health Services (AHS) has approved...

Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins

Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI)Cilastatin is particularly well suited to prevent AKI caused by drug toxins due to its...

Arch Biopartners Closes Non-Brokered Private Placement

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the...

Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University of Calgary’s Conjoint Health...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ARCH - Frequently Asked Questions (FAQ)

What is the current Arch Biopartners share price?

The current share price of Arch Biopartners is $ 2.00

How many Arch Biopartners shares are in issue?

Arch Biopartners has 62,598,000 shares in issue

What is the market cap of Arch Biopartners?

The market capitalisation of Arch Biopartners is CAD 121.44M

What is the 1 year trading range for Arch Biopartners share price?

Arch Biopartners has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Arch Biopartners?

The price to earnings ratio of Arch Biopartners is -37.66

What is the cash to sales ratio of Arch Biopartners?

The cash to sales ratio of Arch Biopartners is 63.09

What is the reporting currency for Arch Biopartners?

Arch Biopartners reports financial results in CAD

What is the latest annual turnover for Arch Biopartners?

The latest annual turnover of Arch Biopartners is CAD 1.98M

What is the latest annual profit for Arch Biopartners?

The latest annual profit of Arch Biopartners is CAD -3.33M

What is the registered address of Arch Biopartners?

The registered address for Arch Biopartners is 27 ST. CLAIR AVENUE EAST, P.O. BOX 305, TORONTO, ONTARIO, M5V 1M1

What is the Arch Biopartners website address?

The website address for Arch Biopartners is archbiopartners.com

Which industry sector does Arch Biopartners operate in?

Arch Biopartners operates in the ADVERTISING AGENCIES sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MUST.HMust Capital Inc	$ 0.06 (200.00%)	165k
KUAI.PKua Investments Inc	$ 0.045 (125.00%)	14k
CRBKCarebook Technologies Inc	$ 0.095 (111.11%)	420.1k
CPLCopper Lake Resources Ltd	$ 0.01 (100.00%)	9k
VKG.HNorse Gold Corp	$ 0.02 (100.00%)	2.16k
TVITVI Pacific Inc	$ 0.005 (-50.00%)	11k
MTBMTB Metals Corp	$ 0.01 (-50.00%)	116.4k
ETUE2gold Inc	$ 0.005 (-50.00%)	10k
KOVOKovo+ Holdings Inc	$ 0.035 (-41.67%)	15k
PORPortofino Resources Inc	$ 0.01 (-33.33%)	349k
MATEBlockmate Ventures Inc	$ 0.41 (38.98%)	9.03M
DMDataMetrex AI Limited	$ 0.005 (0.00%)	4.48M
THRMTherma Bright Inc	$ 0.04 (14.29%)	3.45M
GPUSAlset AI Ventures Inc	$ 0.16 (-3.03%)	2.41M
SSESilver Spruce Resources Inc	$ 0.005 (0.00%)	2.14M